ICYMI, this week we had stories on hormonal acne, skin cancer testing, and more.
Panelists share which factors they use to determine optimal therapy in the moderate to severe plaque psoriasis setting.
Maui Derm begins today in Maui, Hawaii, offering a multitude of presentations and workshops for the dermatology community.
Moving on to the second patient case, panelists discuss switching therapy at treatment failure for plaque psoriasis.
Patients suffering from several dermatologic diseases and conditions including acne, rosacea, and pruritus can largely benefit from the new and exciting therapies and treatment modalities that have recently become available.
Neal Bhatia, MD, highlights the most exciting new drugs and therapies in atopic dermatitis and psoriasis in his presentation at the current Maui Derm for Dermatologists meeting.
Melanoma in Black patients presents unique challenges for dermatologists due to clinical diagnostic differences, provider bias, and a lack of patient awareness, according to a presentation given at Maui Derm 2022.
Vial’s newly launched contract research organization (CRO) addressed ways to surmount some of the biggest obstacles blocking increased speed and quality of clinical trials with an advisory board meeting at Maui Derm for Dermatologists 2022.
Patients suffering from a wide range of dermatologic diseases can benefit from the new and exciting therapies and treatment modalities that have recently become available.
Hyperpigmentation requires dermatologists to take a multimodal approach and be familiar with a menu of treatments, according to a presentation given at Maui Derm for Dermatologists 2022, held January 24 to 28, 2022 in Maui Hawaii, and virtual.
Mono- and combination therapies offer choices for treatments that clear skin with fewer adverse effects.
New and exciting topical and oral therapies for psoriasis have changed the way dermatologists treat and manage their psoriasis patients.
Linda Stein Gold, MD, and Matthew Zirwas, MD, share some advice for clinicians on how to discuss JAK inhibitors with patients.
Julie Harper, MD, of the Dermatology and Skin Care Center of Birmingham, Alabama explained the use, side effects, and risks of spironolactone and oral contraceptives in a presentation at the current Maui Derm for Dermatologists meeting in Maui, Hawaii.
Linda Stein Gold, MD, discusses psoriasis in 2022, in her presentation at the current Maui Derm for Dermatologists meeting.
A poster presentation from Follica at the 2022 Winter Clinical Dermatology Conference and 2022 Maui Derm for Dermatology meeting found that 56% of survey responders did not seek treatment for their hair loss, and that 19% of respondents who attempted treatment quit because of lack of efficacy or cost.
Improve patient outcomes in wound healing with the best practices of time-honored and cutting-edge approaches.
A long-term study of 2 British cohorts with atopic dermatitis (AD) reveals 4 distinct disease patterns occurring between birth and midlife.
A retrospective cohort study in a research letter published in the Journal of the American Academy of Dermatology examined the risk between atopic dermatitis and COVID-19 risk.
Robert S. Kirsner, MD, PhD, discusses new and tried-and-true wound healing methods in his presentation at the Maui Derm for Dermatologists meeting.
Suneel Chilukuri, MD, discusses new innovations in dermatology, including hyperpigmentation, in his presentation at the Maui Derm for Dermatologists meeting.
AbbVie announced the FDA approval to their IL-23 inhibitor risankizumab-rzaa (Skyrizi) for treatment of active psoriatic arthritis (PsA) in adult patients based on the results of the KEEPsAKE-1 and KEEPsAKE-2 trials.
Poster presented at Maui Derm for Dermatologists 2022 reveals prognostic value of 2 independently validated algorithms.
Suneel Chilukuri, MD, discusses lower eyelid rejuvenation, including avoiding complications, in his presentation at the Maui Derm for Dermatologists meeting.
Nearly half of the respondents say there is widespread racism in nursing.